Camargo

NOVEMBER 11, 2020

In October, Antares Pharma licensed Ferring Pharmaceuticals’ Nocdurna® (desmopressin acetate) sublingual tablet , which was approved in 2018 for the same indication as Noctiva and has a boxed warning highlighting the same risks. In 2019, Foundation Medicine and Bayer Healthcare Pharmaceuticals, Inc.

Development 242

Development Bioequivalency Generic Drugs Production 242

Outsourcing Pharma

DECEMBER 12, 2023

Clinical-stage pharma company, PharmaKure which develops precision medicine for Alzheimerâs Disease and other neurological diseases has announced a collaboration agreement with one of the largest comprehensive universities in Malaysia.

Pharma Companies 93

Pharma Companies Medicine Development Regulation 93

pharmaphorum

OCTOBER 28, 2020

Claus Møldrup explores research showing that patients want their voice to be heard more by pharma, and asks what a truly effective feedback loop for medicines might look like. Pharma remains stubbornly closed to feedback, with potentially damaging consequences for the industry, healthcare systems and patients.

Medicine 119

Medicine Pharma Companies Vaccination Vaccine 119

pharmaphorum

NOVEMBER 5, 2020

Talking Medicines has raised £1.1 million) in funding that will be used to develop an artificial intelligence (AI) data platform that can be used by pharma companies to gain insights into how patients perceive them. To date Talking Medicines has raised £2.5 million ($1.4

Medicine 59

Medicine Pharma Companies Branding Regulation 59

pharmaphorum

SEPTEMBER 30, 2021

Now, the FDA has published its first take on sourcing real-world data (RWD) from EHRs and medical claims, setting out its thinking on the approach that should be used to support regulatory filings for medicines. The FDA stresses it is a preliminary document and is encouraging comments, which can be filed up to 60 days after publication.

Pharma Companies 95

Pharma Companies Regulation Clinical Trials Clinical Trials 95

pharmaphorum

DECEMBER 7, 2020

Bureaucracy, political upheaval, and lack of regulations continue to make Latin America a difficult market for European and North American pharma to enter – and COVID-19 has only worsened these issues. For example, price regulations are becoming more common in Latin America, often being based on models such as NICE’s.

Marketing 109

Marketing Regulation Production Medicine 109

World of DTC Marketing

JUNE 22, 2022

PBMs, insurers, pharma companies, and hospitals don’t want to give up their profits even if it’s better for the general population. The company has hired former senior health regulators to help it navigate America’s healthcare bureaucracy. .

Pharmacy 227

Pharmacy Generic Drugs Life Science Branding 227

pharmaphorum

JANUARY 26, 2023

Guidance on the way pharma companies communicate about prescription medicines has been updated in the UK to cover use of social media channels for the first time. It has drawn up the guidance with the help of the companies, the ABPI, and UK regulator the MHRA.

Medicine 105

Medicine Pharma Companies Clinical Trials Clinical Trials 105

pharmaphorum

OCTOBER 18, 2021

There was a genuine sense of alliance; regulatory bodies and pharma companies coming together to accelerate processes and find the most optimal model for collaboration. In addition to data obtained in a clinical setting, information from outside of the clinic can contribute to understanding how a medicine works in daily life.”.

Vaccination 143

Vaccination Vaccine Medicine Regulation 143

Outsourcing Pharma

MAY 23, 2024

A new report from Access to Medicine Foundation gives the advice to ensure the few promising antimicrobials in development reach patients on the frontlines of drug resistance.

Pharma Companies 52

Pharma Companies Drugs Medicine Development 52

pharmaphorum

MARCH 26, 2021

The UK Government and EU Commission trumpeted their Brexit trade deal, struck at the end of December, as ‘comprehensive’, the ‘biggest yet’ But a closer inspection of the EU-UK Trade and Cooperation Agreement (TCA) renders these statements largely illusory for the pharma sector. Medical devices do not feature at all.

Production 119

Production Medicine Marketing Regulation 119

pharmaphorum

NOVEMBER 13, 2020

The European Medicines Agency has announced rolling reviews of vaccines from mainstream pharma companies including Pfizer/BioNTech and AstraZeneca, which allow regulators to review data in real time, allowing them to reach a conclusion quickly.

Vaccination 115

Vaccination Vaccine Pharma Companies Containment 115

pharmaphorum

JANUARY 8, 2021

The global pandemic has caused pharma companies to invest in digital marketing, as healthcare systems across the world adapt to strict lockdown rules. Healthcare companies have been in the vanguard of this change, with an enormous rise in the use of telehealth and all forms of digital communications. This is an increase in 14.2%

Marketing 100

Marketing Doctor Doctors Pharma Companies 100

pharmaphorum

JANUARY 29, 2021

Sangamo CEO Sandy Macrae told us how his company is being cautious about the hype and finding ways to be financially viable in an emerging space. It has also built its own manufacturing site and launched partnerships with six big pharma companies. The genomic medicine journey. That would just slow the whole field down.

Gene Editing 145

Gene Editing Gene Gene Therapy In-Vivo 145

pharmaphorum

JULY 15, 2021

The UK’s competition authority has issued its largest ever fine of more than £260 million ($360 million) to several pharma companies accused of colluding to hike the price of medicines delivered to the NHS.

Marketing 119

Marketing Sales Pharma Companies Medicine 119

pharmaphorum

DECEMBER 10, 2020

The European Medicines Agency (EMA) says it suffered a cyberattack, with documents relating to a Pfizer and BioNTech’s COVID-19 vaccine accessed.

Vaccination 111

Vaccination Vaccine Pharma Companies Medicine 111

pharmaphorum

MAY 25, 2022

The move to online international meetings has left pharma companies with uncertainty around contact compliance. To say the world of work has changed is something of an understatement in the pharma and biopharma industry. But new joint guidance, from the IFPMA, EFPIA, and PhRMA, provides clarity.

Regulation 105

Regulation Compliance Manufacturing Medicine 105

pharmaphorum

NOVEMBER 16, 2020

EMA executive director Guido Rasi has ended his second term at the helm of the EU medicines regulator, with Emer Cooke taking the wheel and becoming the first women in the role. Cooke is returning to the EMA after a four-year period as head of medicines regulation at the World Health Organization (WHO). Emer Cooke.

Regulation 64

Regulation Medicine Vaccination Vaccine 64

Pharmaceutical Technology

JANUARY 31, 2023

FDA director Robert Califf gave his prognosis for the pharma industry at this year’s JP Morgan Healthcare Conference in San Francisco over January 9–12. That leaves three years for pharma companies to prepare. asked panel chair Ipsita Smolinski, MD of consultancy Capitol Street. It’s much needed. It’s a hot area.”

Drugs 130

Drugs Gene Therapy Regulation Insulin 130

pharmaphorum

APRIL 30, 2021

Savana’s Dr Ignacio Medrano explains how natural language processing technology is opening up huge amounts of previously-inaccessible real-world evidence for pharma and regulators. From representation to empowerment: Putting patients at the centre of medicine reimbursement . AI meets RWE: The future of drug assessment?

Marketing 98

Marketing Sales Regulation Drugs 98

Pharmaceutical Technology

MAY 24, 2023

The ability to modify or introduce genetic material in human cells in such a precise and patient-centered manner clearly constitutes a breakthrough in personalized medicine. plan a, plan b, … charter flight standby option).

Clinical Trials 246

Clinical Trials Clinical Trials Gene Therapy Clinical Supply Chain 246

pharmaphorum

SEPTEMBER 15, 2020

Pharma’s go-to-market strategies have tended to be more traditional than those seen in non-regulated sectors, but there are some signs this is changing, with an acceleration in the pace of change forced by the COVID-19 pandemic that is allowing the industry to close its gap with faster, more nimble consumer brands. “The

Branding 130

Branding Marketing Pharma Companies Life Science 130

Fossil Remedies

OCTOBER 16, 2022

When you launch a PCD pharma company , you have to do several preparations. In a pharma business, you have a distribution network like a pharma manufacturing company, pharma marketing company, C&F agents, wholesalers/distributors/stockiest, retailers, and pharmacies. Retail Drug License.

Licensing 52

Licensing Licensing Pharma Companies Manufacturing 52

pharmaphorum

NOVEMBER 3, 2021

The development of digital medicine requires valid endpoints that can be used in clinical trials, and a consortium of pharma companies has just identified a new one for atopic dermatitis.

Development 72

Development Pharma Companies Trials Clinical Trials 72

Pharma Marketing Network

DECEMBER 31, 2024

Ensure Regulatory Compliance Navigating regulations can feel daunting, but its crucial. Monitor Industry Trends Stay informed about market trends like the rise of telehealth, personalized medicine, and value-based care. Why is digital marketing crucial for pharma companies? Disclaimer: This content is not medical advice.

Marketing 52

Marketing Branding Compliance Drugs 52

pharmaphorum

NOVEMBER 3, 2022

The Digital Medicine Society’s Library of Digital Endpoints surpassed 350 unique digital endpoints used for evaluating new medical products. Pharma companies with more mature digital strategies are able to focus on questions of scale. Pharma companies that aren’t asking these questions of scale risk being left behind.

Clinical Trials 81

Clinical Trials Clinical Trials Trials Medicine 81

pharmaphorum

JUNE 16, 2022

There are already more than 30 DiGAs that have approved for use by the BfArM medical regulator and are covered by the national GKV health insurance system.

Hormones 103

Hormones Pharma Companies Regulation Drugs 103

pharmaphorum

NOVEMBER 23, 2020

Pharma companies, healthcare providers and governments share a well-established common purpose: the desire to make disease a thing of the past. I saw a statistic in a Health Europe article, published in September this year, which reported that 81% of patients do not feel listened to by pharma companies.

Pharma Companies 128

Pharma Companies Regulation Development Compliance 128

pharmaphorum

FEBRUARY 14, 2022

In figures, this was represented by 71% of late-stage pipeline revenue being the result of the companies partnering to develop an asset. Due to the increase in funding, more biotechs and smaller scale pharma companies are able to progress assets further into clinical trials.

Production 98

Production Clinical Trials Clinical Trials Sales 98

pharmaphorum

APRIL 19, 2021

It’s been eventful 12-month period for the UK biotech guru Clive Dix, who has just seen his company C4X Discovery clinch a major inflammatory diseases deal with Sanofi. The collective effort has seen trials involving thousands of people set up in a matter of weeks, as pharma was looking for places to test potential vaccines and therapies. “If

Vaccination 98

Vaccination Vaccine Life Science Antibody 98

pharmaphorum

MAY 27, 2022

This is the second in a two-part series examining how pharma can embrace the DEI agenda to create more effective medicines through more representative clinical trials. There is a huge opportunity for pharma companies to capitalise on by focusing on increased DEI in clinical trials. What comes next? About the interviewees.

Clinical Trials 80

Clinical Trials Clinical Trials Trials Packaging 80

pharmaphorum

JULY 14, 2022

A pilot study has been launched by the EMA to see whether it is helpful for regulators to look at the ‘raw data’ from clinical trials submitted in support of new marketing application along with the usual structured analyses from sponsors. It may also help the regulator to define target treatment populations better.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Regulation 52

pharmaphorum

NOVEMBER 30, 2022

The question is, how can the journey there be accelerated, when on the horizon awaits a life sciences future very much immersed in speciality medicine? The biggest gathering of pharma companies in Europe right now on the commercial side, the Veeva Systems Summit permits the sharing of best practices and of new ideas.

Life Science 98

Life Science Pharma Companies Sales Marketing 98

pharmaphorum

APRIL 22, 2021

Biosensor firm physIQ has licensed its technology to Johnson & Johnson’s Janssen pharma unit in a multi-year deal, to investigate use of wearable sensors in virtual clinical trials. The pharma company will use the technology known as accelerateIQ to collect data across its clinical studies through a variety of wearable biosensors.

Licensing 72

Licensing Licensing Trials Clinical Trials 72

Pharma Marketing Network

OCTOBER 17, 2024

Moreover, the adoption of digital tools like mobile apps and telemedicine platforms is facilitating direct communication between pharma companies and end-users. As patients become more digitally savvy, pharma companies are investing in creating seamless digital experiences that cater to their needs and preferences.

Marketing 52

Marketing Pharma Companies Regulation Production 52

pharmaphorum

JANUARY 24, 2022

The UK scientists that ran one of the largest trials of experimental COVID-19 drugs have formed a non-profit company that will apply the methodology to other disease areas – with $6.8 million in funding from French drugmaker Sanofi.

Trials 97

Trials Drugs Clinical Trials Clinical Trials 97

Pharma Marketing Network

JANUARY 29, 2025

Personalized Medicine and Precision Targeting Gone are the days of one-size-fits-all treatments. Personalized medicine is revolutionizing pharma marketing by tailoring treatments to individual genetic profiles, lifestyles, and medical histories. How does this impact pharma marketing?

Marketing 52

Marketing Compliance Big Data Branding 52